Oral anticoagulant therapy: practical aspects of management

作者: Malcolm L. Brigden

DOI: 10.1080/00325481.1996.11946138

关键词:

摘要: Careful attention to the practical aspects of oral anticoagulant therapy can improve patient compliance and lessen risk bleeding complications. A variety factors for associated with have been defined should be assessed before initiating therapy. Recent investigations provided a means estimating what constitutes significant change in an individual patient's serial International Normalized Ratio (INR) by allowing combined analytic biologic variation prothrombin time determinations. Dosing adjustments warfarin sodium (Coumadin, Panwarfin, Sofarin) appropriate level INR spread over total weekly dosage optimum stable control. Elderly patients are more sensitive any given dose need significantly lower dose. Attention must paid vitamin K content diet additional factors, including other drug therapy, alcohol consumption, metabolic status. Hematuria or gastrointestinal always assessed, because chance finding clinically lesion is good, especially when has therapeutic range. Although minor prolongation without may treated watchful waiting, administration measures necessary active bleeding. Comprehensive education paramount facilitated checklist approach. well-informed provides one best defenses against

参考文章(24)
H I Bussey, How to monitor the dosage of warfarin. Heart disease and stroke : a journal for primary care physicians. ,vol. 2, pp. 388- 392 ,(1993)
S Kumar, J R M Haigh, L E Rhodes, S Peaker, J A Davies, B E Roberts, M P Feely, Poor compliance is a major factor in unstable outpatient control of anticoagulant therapy. Thrombosis and Haemostasis. ,vol. 62, pp. 729- 732 ,(1989) , 10.1055/S-0038-1646892
Scott H. Jr. M.D. Goodnight, William E. M.D. Hathaway, Disorders of Hemostasis and Thrombosis: A Clinical Guide ,(1993)
Sarah L. Booth, James A. Sadowski, John L. Weihrauch, Guylaine Ferland, Vitamin K1 (Phylloquinone) Content of Foods: A Provisional Table Journal of Food Composition and Analysis. ,vol. 6, pp. 109- 120 ,(1993) , 10.1006/JFCA.1993.1014
Richard H White, Tara McKittrick, Rose Hutchinson, Jeff Twitchell, Temporary Discontinuation of Warfarin Therapy: Changes in the International Normalized Ratio Annals of Internal Medicine. ,vol. 122, pp. 40- 42 ,(1995) , 10.7326/0003-4819-122-1-199501010-00006
Stephan D Fihn, Mary McDonell, Donald Martin, Jorja Henikoff, Domokos Vermes, Daniel Kent, Richard H White, Warfarin Optimized Outpatient Follow-up Study Group*, Risk Factors for Complications of Chronic Anticoagulation: A Multicenter Study Annals of Internal Medicine. ,vol. 118, pp. 511- 520 ,(1993) , 10.7326/0003-4819-118-7-199304010-00005
Scott C. Litin, Dennis A. Gastineau, Current Concepts in Anticoagulant Therapy Mayo Clinic Proceedings. ,vol. 70, pp. 266- 272 ,(1995) , 10.4065/70.3.266
Jack Hirsh, Leon Poller, The international normalized ratio. A guide to understanding and correcting its problems Archives of Internal Medicine. ,vol. 154, pp. 282- 288 ,(1994) , 10.1001/ARCHINTE.154.3.282
Thomas C. Andrews, David W. Peterson, Dennis Doeppenschmidt, Jeff S. Foster, Michael J. Lucca, Joseph A. Deering, Paul J. Laveau, Complications of warfarin therapy monitored by the international normalized ratio versus the prothrombin time ratio Clinical Cardiology. ,vol. 18, pp. 80- 82 ,(1995) , 10.1002/CLC.4960180208
Jack Hirsh, Optimal intensity and monitoring warfarin American Journal of Cardiology. ,vol. 75, pp. 39- ,(1995) , 10.1016/0002-9149(95)80009-H